0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Non-Invasive Drug Delivery Device Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-36T7597
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Non Invasive Drug Delivery Device Market Insights Forecast to 2028
BUY CHAPTERS

Global Non-Invasive Drug Delivery Device Market Research Report 2025

Code: QYRE-Auto-36T7597
Report
July 2025
Pages:95
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Non-Invasive Drug Delivery Device Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Non-Invasive Drug Delivery Device Market

Non-Invasive Drug Delivery Device Market

The global market for Non-Invasive Drug Delivery Device was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Non-Invasive Drug Delivery refers to the different administration forms of various therapeutic drugs that people use in the process of preventing and treating diseases without invasion.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Non-Invasive Drug Delivery Device, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Non-Invasive Drug Delivery Device.
The Non-Invasive Drug Delivery Device market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Non-Invasive Drug Delivery Device market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Non-Invasive Drug Delivery Device manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Non-Invasive Drug Delivery Device Market Report

Report Metric Details
Report Name Non-Invasive Drug Delivery Device Market
CAGR 5%
Segment by Type
  • Liquid-Based Needle-Free Injector
  • Powder-Based Needle-Free Injector
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Novartis AG, Inovio Pharmaceuticals, Inc., Medtronic Plc., Tandem Diabetes Care, Inc., Teva Pharmaceutical Industries Ltd., Crossject Medical Technology, Adherium Ltd., Sensirion AG, Diabeloop, PharmaJet, PenJet, Portal Instruments, Capsule Technologies, Propeller Health
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Non-Invasive Drug Delivery Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Non-Invasive Drug Delivery Device in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Non-Invasive Drug Delivery Device Market report?

Ans: The main players in the Non-Invasive Drug Delivery Device Market are Novartis AG, Inovio Pharmaceuticals, Inc., Medtronic Plc., Tandem Diabetes Care, Inc., Teva Pharmaceutical Industries Ltd., Crossject Medical Technology, Adherium Ltd., Sensirion AG, Diabeloop, PharmaJet, PenJet, Portal Instruments, Capsule Technologies, Propeller Health

What are the Application segmentation covered in the Non-Invasive Drug Delivery Device Market report?

Ans: The Applications covered in the Non-Invasive Drug Delivery Device Market report are Diabetes Management, Vaccine Management, Pain Management, Respiratory Management, Others

What are the Type segmentation covered in the Non-Invasive Drug Delivery Device Market report?

Ans: The Types covered in the Non-Invasive Drug Delivery Device Market report are Liquid-Based Needle-Free Injector, Powder-Based Needle-Free Injector

Recommended Reports

Drug Delivery Devices

Therapeutic Applications

Innovative Delivery

1 Non-Invasive Drug Delivery Device Market Overview
1.1 Product Definition
1.2 Non-Invasive Drug Delivery Device by Type
1.2.1 Global Non-Invasive Drug Delivery Device Market Value Comparison by Type (2024 VS 2031)
1.2.2 Liquid-Based Needle-Free Injector
1.2.3 Powder-Based Needle-Free Injector
1.3 Non-Invasive Drug Delivery Device by Application
1.3.1 Global Non-Invasive Drug Delivery Device Market Value by Application (2024 VS 2031)
1.3.2 Diabetes Management
1.3.3 Vaccine Management
1.3.4 Pain Management
1.3.5 Respiratory Management
1.3.6 Others
1.4 Global Non-Invasive Drug Delivery Device Market Size Estimates and Forecasts
1.4.1 Global Non-Invasive Drug Delivery Device Revenue 2020-2031
1.4.2 Global Non-Invasive Drug Delivery Device Sales 2020-2031
1.4.3 Global Non-Invasive Drug Delivery Device Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Non-Invasive Drug Delivery Device Market Competition by Manufacturers
2.1 Global Non-Invasive Drug Delivery Device Sales Market Share by Manufacturers (2020-2025)
2.2 Global Non-Invasive Drug Delivery Device Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Non-Invasive Drug Delivery Device Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Non-Invasive Drug Delivery Device, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Non-Invasive Drug Delivery Device, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Non-Invasive Drug Delivery Device, Product Type & Application
2.7 Global Key Manufacturers of Non-Invasive Drug Delivery Device, Date of Enter into This Industry
2.8 Global Non-Invasive Drug Delivery Device Market Competitive Situation and Trends
2.8.1 Global Non-Invasive Drug Delivery Device Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Non-Invasive Drug Delivery Device Players Market Share by Revenue
2.8.3 Global Non-Invasive Drug Delivery Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Non-Invasive Drug Delivery Device Market Scenario by Region
3.1 Global Non-Invasive Drug Delivery Device Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Non-Invasive Drug Delivery Device Sales by Region: 2020-2031
3.2.1 Global Non-Invasive Drug Delivery Device Sales by Region: 2020-2025
3.2.2 Global Non-Invasive Drug Delivery Device Sales by Region: 2026-2031
3.3 Global Non-Invasive Drug Delivery Device Revenue by Region: 2020-2031
3.3.1 Global Non-Invasive Drug Delivery Device Revenue by Region: 2020-2025
3.3.2 Global Non-Invasive Drug Delivery Device Revenue by Region: 2026-2031
3.4 North America Non-Invasive Drug Delivery Device Market Facts & Figures by Country
3.4.1 North America Non-Invasive Drug Delivery Device Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Non-Invasive Drug Delivery Device Sales by Country (2020-2031)
3.4.3 North America Non-Invasive Drug Delivery Device Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Non-Invasive Drug Delivery Device Market Facts & Figures by Country
3.5.1 Europe Non-Invasive Drug Delivery Device Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Non-Invasive Drug Delivery Device Sales by Country (2020-2031)
3.5.3 Europe Non-Invasive Drug Delivery Device Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Non-Invasive Drug Delivery Device Market Facts & Figures by Region
3.6.1 Asia Pacific Non-Invasive Drug Delivery Device Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Non-Invasive Drug Delivery Device Sales by Region (2020-2031)
3.6.3 Asia Pacific Non-Invasive Drug Delivery Device Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Non-Invasive Drug Delivery Device Market Facts & Figures by Country
3.7.1 Latin America Non-Invasive Drug Delivery Device Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Non-Invasive Drug Delivery Device Sales by Country (2020-2031)
3.7.3 Latin America Non-Invasive Drug Delivery Device Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Non-Invasive Drug Delivery Device Market Facts & Figures by Country
3.8.1 Middle East and Africa Non-Invasive Drug Delivery Device Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Non-Invasive Drug Delivery Device Sales by Country (2020-2031)
3.8.3 Middle East and Africa Non-Invasive Drug Delivery Device Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Non-Invasive Drug Delivery Device Sales by Type (2020-2031)
4.1.1 Global Non-Invasive Drug Delivery Device Sales by Type (2020-2025)
4.1.2 Global Non-Invasive Drug Delivery Device Sales by Type (2026-2031)
4.1.3 Global Non-Invasive Drug Delivery Device Sales Market Share by Type (2020-2031)
4.2 Global Non-Invasive Drug Delivery Device Revenue by Type (2020-2031)
4.2.1 Global Non-Invasive Drug Delivery Device Revenue by Type (2020-2025)
4.2.2 Global Non-Invasive Drug Delivery Device Revenue by Type (2026-2031)
4.2.3 Global Non-Invasive Drug Delivery Device Revenue Market Share by Type (2020-2031)
4.3 Global Non-Invasive Drug Delivery Device Price by Type (2020-2031)
5 Segment by Application
5.1 Global Non-Invasive Drug Delivery Device Sales by Application (2020-2031)
5.1.1 Global Non-Invasive Drug Delivery Device Sales by Application (2020-2025)
5.1.2 Global Non-Invasive Drug Delivery Device Sales by Application (2026-2031)
5.1.3 Global Non-Invasive Drug Delivery Device Sales Market Share by Application (2020-2031)
5.2 Global Non-Invasive Drug Delivery Device Revenue by Application (2020-2031)
5.2.1 Global Non-Invasive Drug Delivery Device Revenue by Application (2020-2025)
5.2.2 Global Non-Invasive Drug Delivery Device Revenue by Application (2026-2031)
5.2.3 Global Non-Invasive Drug Delivery Device Revenue Market Share by Application (2020-2031)
5.3 Global Non-Invasive Drug Delivery Device Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Novartis AG
6.1.1 Novartis AG Company Information
6.1.2 Novartis AG Description and Business Overview
6.1.3 Novartis AG Non-Invasive Drug Delivery Device Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Novartis AG Non-Invasive Drug Delivery Device Product Portfolio
6.1.5 Novartis AG Recent Developments/Updates
6.2 Inovio Pharmaceuticals, Inc.
6.2.1 Inovio Pharmaceuticals, Inc. Company Information
6.2.2 Inovio Pharmaceuticals, Inc. Description and Business Overview
6.2.3 Inovio Pharmaceuticals, Inc. Non-Invasive Drug Delivery Device Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Inovio Pharmaceuticals, Inc. Non-Invasive Drug Delivery Device Product Portfolio
6.2.5 Inovio Pharmaceuticals, Inc. Recent Developments/Updates
6.3 Medtronic Plc.
6.3.1 Medtronic Plc. Company Information
6.3.2 Medtronic Plc. Description and Business Overview
6.3.3 Medtronic Plc. Non-Invasive Drug Delivery Device Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Medtronic Plc. Non-Invasive Drug Delivery Device Product Portfolio
6.3.5 Medtronic Plc. Recent Developments/Updates
6.4 Tandem Diabetes Care, Inc.
6.4.1 Tandem Diabetes Care, Inc. Company Information
6.4.2 Tandem Diabetes Care, Inc. Description and Business Overview
6.4.3 Tandem Diabetes Care, Inc. Non-Invasive Drug Delivery Device Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Tandem Diabetes Care, Inc. Non-Invasive Drug Delivery Device Product Portfolio
6.4.5 Tandem Diabetes Care, Inc. Recent Developments/Updates
6.5 Teva Pharmaceutical Industries Ltd.
6.5.1 Teva Pharmaceutical Industries Ltd. Company Information
6.5.2 Teva Pharmaceutical Industries Ltd. Description and Business Overview
6.5.3 Teva Pharmaceutical Industries Ltd. Non-Invasive Drug Delivery Device Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Teva Pharmaceutical Industries Ltd. Non-Invasive Drug Delivery Device Product Portfolio
6.5.5 Teva Pharmaceutical Industries Ltd. Recent Developments/Updates
6.6 Crossject Medical Technology
6.6.1 Crossject Medical Technology Company Information
6.6.2 Crossject Medical Technology Description and Business Overview
6.6.3 Crossject Medical Technology Non-Invasive Drug Delivery Device Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Crossject Medical Technology Non-Invasive Drug Delivery Device Product Portfolio
6.6.5 Crossject Medical Technology Recent Developments/Updates
6.7 Adherium Ltd.
6.7.1 Adherium Ltd. Company Information
6.7.2 Adherium Ltd. Description and Business Overview
6.7.3 Adherium Ltd. Non-Invasive Drug Delivery Device Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Adherium Ltd. Non-Invasive Drug Delivery Device Product Portfolio
6.7.5 Adherium Ltd. Recent Developments/Updates
6.8 Sensirion AG
6.8.1 Sensirion AG Company Information
6.8.2 Sensirion AG Description and Business Overview
6.8.3 Sensirion AG Non-Invasive Drug Delivery Device Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Sensirion AG Non-Invasive Drug Delivery Device Product Portfolio
6.8.5 Sensirion AG Recent Developments/Updates
6.9 Diabeloop
6.9.1 Diabeloop Company Information
6.9.2 Diabeloop Description and Business Overview
6.9.3 Diabeloop Non-Invasive Drug Delivery Device Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Diabeloop Non-Invasive Drug Delivery Device Product Portfolio
6.9.5 Diabeloop Recent Developments/Updates
6.10 PharmaJet
6.10.1 PharmaJet Company Information
6.10.2 PharmaJet Description and Business Overview
6.10.3 PharmaJet Non-Invasive Drug Delivery Device Sales, Revenue and Gross Margin (2020-2025)
6.10.4 PharmaJet Non-Invasive Drug Delivery Device Product Portfolio
6.10.5 PharmaJet Recent Developments/Updates
6.11 PenJet
6.11.1 PenJet Company Information
6.11.2 PenJet Description and Business Overview
6.11.3 PenJet Non-Invasive Drug Delivery Device Sales, Revenue and Gross Margin (2020-2025)
6.11.4 PenJet Non-Invasive Drug Delivery Device Product Portfolio
6.11.5 PenJet Recent Developments/Updates
6.12 Portal Instruments
6.12.1 Portal Instruments Company Information
6.12.2 Portal Instruments Description and Business Overview
6.12.3 Portal Instruments Non-Invasive Drug Delivery Device Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Portal Instruments Non-Invasive Drug Delivery Device Product Portfolio
6.12.5 Portal Instruments Recent Developments/Updates
6.13 Capsule Technologies
6.13.1 Capsule Technologies Company Information
6.13.2 Capsule Technologies Description and Business Overview
6.13.3 Capsule Technologies Non-Invasive Drug Delivery Device Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Capsule Technologies Non-Invasive Drug Delivery Device Product Portfolio
6.13.5 Capsule Technologies Recent Developments/Updates
6.14 Propeller Health
6.14.1 Propeller Health Company Information
6.14.2 Propeller Health Description and Business Overview
6.14.3 Propeller Health Non-Invasive Drug Delivery Device Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Propeller Health Non-Invasive Drug Delivery Device Product Portfolio
6.14.5 Propeller Health Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Non-Invasive Drug Delivery Device Industry Chain Analysis
7.2 Non-Invasive Drug Delivery Device Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Non-Invasive Drug Delivery Device Production Mode & Process Analysis
7.4 Non-Invasive Drug Delivery Device Sales and Marketing
7.4.1 Non-Invasive Drug Delivery Device Sales Channels
7.4.2 Non-Invasive Drug Delivery Device Distributors
7.5 Non-Invasive Drug Delivery Device Customer Analysis
8 Non-Invasive Drug Delivery Device Market Dynamics
8.1 Non-Invasive Drug Delivery Device Industry Trends
8.2 Non-Invasive Drug Delivery Device Market Drivers
8.3 Non-Invasive Drug Delivery Device Market Challenges
8.4 Non-Invasive Drug Delivery Device Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Non-Invasive Drug Delivery Device Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Non-Invasive Drug Delivery Device Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Non-Invasive Drug Delivery Device Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Non-Invasive Drug Delivery Device Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Non-Invasive Drug Delivery Device Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Non-Invasive Drug Delivery Device Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Non-Invasive Drug Delivery Device Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Non-Invasive Drug Delivery Device Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Non-Invasive Drug Delivery Device, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Non-Invasive Drug Delivery Device, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Non-Invasive Drug Delivery Device, Product Type & Application
 Table 12. Global Key Manufacturers of Non-Invasive Drug Delivery Device, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Non-Invasive Drug Delivery Device by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Invasive Drug Delivery Device as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Non-Invasive Drug Delivery Device Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Non-Invasive Drug Delivery Device Sales by Region (2020-2025) & (K Units)
 Table 18. Global Non-Invasive Drug Delivery Device Sales Market Share by Region (2020-2025)
 Table 19. Global Non-Invasive Drug Delivery Device Sales by Region (2026-2031) & (K Units)
 Table 20. Global Non-Invasive Drug Delivery Device Sales Market Share by Region (2026-2031)
 Table 21. Global Non-Invasive Drug Delivery Device Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Non-Invasive Drug Delivery Device Revenue Market Share by Region (2020-2025)
 Table 23. Global Non-Invasive Drug Delivery Device Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Non-Invasive Drug Delivery Device Revenue Market Share by Region (2026-2031)
 Table 25. North America Non-Invasive Drug Delivery Device Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Non-Invasive Drug Delivery Device Sales by Country (2020-2025) & (K Units)
 Table 27. North America Non-Invasive Drug Delivery Device Sales by Country (2026-2031) & (K Units)
 Table 28. North America Non-Invasive Drug Delivery Device Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Non-Invasive Drug Delivery Device Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Non-Invasive Drug Delivery Device Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Non-Invasive Drug Delivery Device Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Non-Invasive Drug Delivery Device Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Non-Invasive Drug Delivery Device Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Non-Invasive Drug Delivery Device Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Non-Invasive Drug Delivery Device Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Non-Invasive Drug Delivery Device Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Non-Invasive Drug Delivery Device Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Non-Invasive Drug Delivery Device Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Non-Invasive Drug Delivery Device Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Non-Invasive Drug Delivery Device Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Non-Invasive Drug Delivery Device Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Non-Invasive Drug Delivery Device Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Non-Invasive Drug Delivery Device Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Non-Invasive Drug Delivery Device Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Non-Invasive Drug Delivery Device Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Non-Invasive Drug Delivery Device Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Non-Invasive Drug Delivery Device Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Non-Invasive Drug Delivery Device Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Non-Invasive Drug Delivery Device Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Non-Invasive Drug Delivery Device Sales (K Units) by Type (2020-2025)
 Table 51. Global Non-Invasive Drug Delivery Device Sales (K Units) by Type (2026-2031)
 Table 52. Global Non-Invasive Drug Delivery Device Sales Market Share by Type (2020-2025)
 Table 53. Global Non-Invasive Drug Delivery Device Sales Market Share by Type (2026-2031)
 Table 54. Global Non-Invasive Drug Delivery Device Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Non-Invasive Drug Delivery Device Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Non-Invasive Drug Delivery Device Revenue Market Share by Type (2020-2025)
 Table 57. Global Non-Invasive Drug Delivery Device Revenue Market Share by Type (2026-2031)
 Table 58. Global Non-Invasive Drug Delivery Device Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Non-Invasive Drug Delivery Device Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Non-Invasive Drug Delivery Device Sales (K Units) by Application (2020-2025)
 Table 61. Global Non-Invasive Drug Delivery Device Sales (K Units) by Application (2026-2031)
 Table 62. Global Non-Invasive Drug Delivery Device Sales Market Share by Application (2020-2025)
 Table 63. Global Non-Invasive Drug Delivery Device Sales Market Share by Application (2026-2031)
 Table 64. Global Non-Invasive Drug Delivery Device Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Non-Invasive Drug Delivery Device Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Non-Invasive Drug Delivery Device Revenue Market Share by Application (2020-2025)
 Table 67. Global Non-Invasive Drug Delivery Device Revenue Market Share by Application (2026-2031)
 Table 68. Global Non-Invasive Drug Delivery Device Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Non-Invasive Drug Delivery Device Price (US$/Unit) by Application (2026-2031)
 Table 70. Novartis AG Company Information
 Table 71. Novartis AG Description and Business Overview
 Table 72. Novartis AG Non-Invasive Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Novartis AG Non-Invasive Drug Delivery Device Product
 Table 74. Novartis AG Recent Developments/Updates
 Table 75. Inovio Pharmaceuticals, Inc. Company Information
 Table 76. Inovio Pharmaceuticals, Inc. Description and Business Overview
 Table 77. Inovio Pharmaceuticals, Inc. Non-Invasive Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Inovio Pharmaceuticals, Inc. Non-Invasive Drug Delivery Device Product
 Table 79. Inovio Pharmaceuticals, Inc. Recent Developments/Updates
 Table 80. Medtronic Plc. Company Information
 Table 81. Medtronic Plc. Description and Business Overview
 Table 82. Medtronic Plc. Non-Invasive Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Medtronic Plc. Non-Invasive Drug Delivery Device Product
 Table 84. Medtronic Plc. Recent Developments/Updates
 Table 85. Tandem Diabetes Care, Inc. Company Information
 Table 86. Tandem Diabetes Care, Inc. Description and Business Overview
 Table 87. Tandem Diabetes Care, Inc. Non-Invasive Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Tandem Diabetes Care, Inc. Non-Invasive Drug Delivery Device Product
 Table 89. Tandem Diabetes Care, Inc. Recent Developments/Updates
 Table 90. Teva Pharmaceutical Industries Ltd. Company Information
 Table 91. Teva Pharmaceutical Industries Ltd. Description and Business Overview
 Table 92. Teva Pharmaceutical Industries Ltd. Non-Invasive Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Teva Pharmaceutical Industries Ltd. Non-Invasive Drug Delivery Device Product
 Table 94. Teva Pharmaceutical Industries Ltd. Recent Developments/Updates
 Table 95. Crossject Medical Technology Company Information
 Table 96. Crossject Medical Technology Description and Business Overview
 Table 97. Crossject Medical Technology Non-Invasive Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Crossject Medical Technology Non-Invasive Drug Delivery Device Product
 Table 99. Crossject Medical Technology Recent Developments/Updates
 Table 100. Adherium Ltd. Company Information
 Table 101. Adherium Ltd. Description and Business Overview
 Table 102. Adherium Ltd. Non-Invasive Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Adherium Ltd. Non-Invasive Drug Delivery Device Product
 Table 104. Adherium Ltd. Recent Developments/Updates
 Table 105. Sensirion AG Company Information
 Table 106. Sensirion AG Description and Business Overview
 Table 107. Sensirion AG Non-Invasive Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Sensirion AG Non-Invasive Drug Delivery Device Product
 Table 109. Sensirion AG Recent Developments/Updates
 Table 110. Diabeloop Company Information
 Table 111. Diabeloop Description and Business Overview
 Table 112. Diabeloop Non-Invasive Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Diabeloop Non-Invasive Drug Delivery Device Product
 Table 114. Diabeloop Recent Developments/Updates
 Table 115. PharmaJet Company Information
 Table 116. PharmaJet Description and Business Overview
 Table 117. PharmaJet Non-Invasive Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. PharmaJet Non-Invasive Drug Delivery Device Product
 Table 119. PharmaJet Recent Developments/Updates
 Table 120. PenJet Company Information
 Table 121. PenJet Description and Business Overview
 Table 122. PenJet Non-Invasive Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. PenJet Non-Invasive Drug Delivery Device Product
 Table 124. PenJet Recent Developments/Updates
 Table 125. Portal Instruments Company Information
 Table 126. Portal Instruments Description and Business Overview
 Table 127. Portal Instruments Non-Invasive Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Portal Instruments Non-Invasive Drug Delivery Device Product
 Table 129. Portal Instruments Recent Developments/Updates
 Table 130. Capsule Technologies Company Information
 Table 131. Capsule Technologies Description and Business Overview
 Table 132. Capsule Technologies Non-Invasive Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Capsule Technologies Non-Invasive Drug Delivery Device Product
 Table 134. Capsule Technologies Recent Developments/Updates
 Table 135. Propeller Health Company Information
 Table 136. Propeller Health Description and Business Overview
 Table 137. Propeller Health Non-Invasive Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Propeller Health Non-Invasive Drug Delivery Device Product
 Table 139. Propeller Health Recent Developments/Updates
 Table 140. Key Raw Materials Lists
 Table 141. Raw Materials Key Suppliers Lists
 Table 142. Non-Invasive Drug Delivery Device Distributors List
 Table 143. Non-Invasive Drug Delivery Device Customers List
 Table 144. Non-Invasive Drug Delivery Device Market Trends
 Table 145. Non-Invasive Drug Delivery Device Market Drivers
 Table 146. Non-Invasive Drug Delivery Device Market Challenges
 Table 147. Non-Invasive Drug Delivery Device Market Restraints
 Table 148. Research Programs/Design for This Report
 Table 149. Key Data Information from Secondary Sources
 Table 150. Key Data Information from Primary Sources
 Table 151. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Non-Invasive Drug Delivery Device
 Figure 2. Global Non-Invasive Drug Delivery Device Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Non-Invasive Drug Delivery Device Market Share by Type: 2024 & 2031
 Figure 4. Liquid-Based Needle-Free Injector Product Picture
 Figure 5. Powder-Based Needle-Free Injector Product Picture
 Figure 6. Global Non-Invasive Drug Delivery Device Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Non-Invasive Drug Delivery Device Market Share by Application: 2024 & 2031
 Figure 8. Diabetes Management
 Figure 9. Vaccine Management
 Figure 10. Pain Management
 Figure 11. Respiratory Management
 Figure 12. Others
 Figure 13. Global Non-Invasive Drug Delivery Device Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Non-Invasive Drug Delivery Device Market Size (2020-2031) & (US$ Million)
 Figure 15. Global Non-Invasive Drug Delivery Device Sales (2020-2031) & (K Units)
 Figure 16. Global Non-Invasive Drug Delivery Device Average Price (US$/Unit) & (2020-2031)
 Figure 17. Non-Invasive Drug Delivery Device Report Years Considered
 Figure 18. Non-Invasive Drug Delivery Device Sales Share by Manufacturers in 2024
 Figure 19. Global Non-Invasive Drug Delivery Device Revenue Share by Manufacturers in 2024
 Figure 20. Global 5 and 10 Largest Non-Invasive Drug Delivery Device Players: Market Share by Revenue in Non-Invasive Drug Delivery Device in 2024
 Figure 21. Non-Invasive Drug Delivery Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 22. Global Non-Invasive Drug Delivery Device Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 23. North America Non-Invasive Drug Delivery Device Sales Market Share by Country (2020-2031)
 Figure 24. North America Non-Invasive Drug Delivery Device Revenue Market Share by Country (2020-2031)
 Figure 25. United States Non-Invasive Drug Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Canada Non-Invasive Drug Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Europe Non-Invasive Drug Delivery Device Sales Market Share by Country (2020-2031)
 Figure 28. Europe Non-Invasive Drug Delivery Device Revenue Market Share by Country (2020-2031)
 Figure 29. Germany Non-Invasive Drug Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. France Non-Invasive Drug Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. U.K. Non-Invasive Drug Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Italy Non-Invasive Drug Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Russia Non-Invasive Drug Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Asia Pacific Non-Invasive Drug Delivery Device Sales Market Share by Region (2020-2031)
 Figure 35. Asia Pacific Non-Invasive Drug Delivery Device Revenue Market Share by Region (2020-2031)
 Figure 36. China Non-Invasive Drug Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Japan Non-Invasive Drug Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. South Korea Non-Invasive Drug Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. India Non-Invasive Drug Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Australia Non-Invasive Drug Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. China Taiwan Non-Invasive Drug Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Indonesia Non-Invasive Drug Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Thailand Non-Invasive Drug Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Malaysia Non-Invasive Drug Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Latin America Non-Invasive Drug Delivery Device Sales Market Share by Country (2020-2031)
 Figure 46. Latin America Non-Invasive Drug Delivery Device Revenue Market Share by Country (2020-2031)
 Figure 47. Mexico Non-Invasive Drug Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Brazil Non-Invasive Drug Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Argentina Non-Invasive Drug Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Middle East and Africa Non-Invasive Drug Delivery Device Sales Market Share by Country (2020-2031)
 Figure 51. Middle East and Africa Non-Invasive Drug Delivery Device Revenue Market Share by Country (2020-2031)
 Figure 52. Turkey Non-Invasive Drug Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Saudi Arabia Non-Invasive Drug Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. UAE Non-Invasive Drug Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Global Sales Market Share of Non-Invasive Drug Delivery Device by Type (2020-2031)
 Figure 56. Global Revenue Market Share of Non-Invasive Drug Delivery Device by Type (2020-2031)
 Figure 57. Global Non-Invasive Drug Delivery Device Price (US$/Unit) by Type (2020-2031)
 Figure 58. Global Sales Market Share of Non-Invasive Drug Delivery Device by Application (2020-2031)
 Figure 59. Global Revenue Market Share of Non-Invasive Drug Delivery Device by Application (2020-2031)
 Figure 60. Global Non-Invasive Drug Delivery Device Price (US$/Unit) by Application (2020-2031)
 Figure 61. Non-Invasive Drug Delivery Device Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure

SIMILAR REPORTS